디앤디파마텍
43,300KRWMarket close of 10/21 (Wed)
Up +6.65%+2,700KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)41,100KRWDown -5.08%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 41,000
- High
- 43,300
- Low
- 40,950
- Day range
- Day range low 40,950 high 43,300, open 41,000, close 43,300, previous close 40,600
- Volume
- 52×10K shares
- 22.0B KRW 0.92× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
10%1-year close range 35,400 to 111,200 won, 10% up from the low
10% of the way up from the lowest close in 1 year (227 sessions) · -61.1% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-37.6B KRWOperating income over the last four quarters -37.6B KRW (loss)
- Daily moveusual range+6.65%+6.65%, 1.5× the usual (20-session average ±4.50%)That day +6.65% · usual ±4.50% · large-move threshold ±9.0%
- Trading valueusual range0.9×22.0B KRW, 0.9× the 20-session average0.92× the 20-session average · check threshold 3×
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+4.8B KRWusual range
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 바이오 R&D
Up +3.03%· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -5.5% | Up +3.90% | 60.7B KRW |
| 올릭스 | Close over the last 20 sessions -6.4% | Up +9.53% | 26.1B KRW |
| 리가켐바이오 | Close over the last 20 sessions -14.3% | Up +2.00% | 12.9B KRW |
| 프로티나 | Close over the last 20 sessions +35.7% | Up +7.23% | 11.0B KRW |
| 알지노믹스 | Close over the last 20 sessions -8.9% | Up +7.26% | 10.5B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 24 days
- Next data 10/23 (Fri) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.